CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics.

Trial Profile

CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Abacavir; Atazanavir; Efavirenz; Emtricitabine; Etravirine; Lamivudine; Lopinavir/ritonavir; Maraviroc; Raltegravir; Ritonavir; Tenofovir disoproxil fumarate; Zidovudine
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Mar 2012 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov record.
    • 19 Jul 2011 Planned end date changed from 1 May 2011 to 1 Jan 2013 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top